Yes, from what I hear, it seems very hard. I’d point you to some recent pieces:
https://www.statnews.com/2022/11/03/why-were-not-prepared-for-next-wave-of-biotech-innovation/
https://milkyeggs.com/biology/why-are-clinical-trials-so-expensive-tales-from-the-beasts-belly/
https://www.nytimes.com/2023/01/27/business/paradigm-startup-clinical-trials.html
Yes, from what I hear, it seems very hard. I’d point you to some recent pieces:
https://www.statnews.com/2022/11/03/why-were-not-prepared-for-next-wave-of-biotech-innovation/
https://milkyeggs.com/biology/why-are-clinical-trials-so-expensive-tales-from-the-beasts-belly/
https://www.nytimes.com/2023/01/27/business/paradigm-startup-clinical-trials.html